Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial
Status: Enrolling
Updated:  2/28/2018
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial
Status: Enrolling
Updated: 2/28/2018
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial
Status: Enrolling
Updated:  2/28/2018
Good Samaritan Hospital
mi
from
Cincinnati, OH
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial
Status: Enrolling
Updated: 2/28/2018
Good Samaritan Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery
Randomized Controlled Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery
Status: Enrolling
Updated:  2/28/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery
Randomized Controlled Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery
Status: Enrolling
Updated: 2/28/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Pilot Study Investigating the Clinical Use of Tissue Engineered Vascular Grafts in Congenital Heart Surgery
A Pilot Study Investigating the Clinical Use of Tissue Engineered Vascular Grafts in Congenital Heart Surgery
Status: Enrolling
Updated:  2/28/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
A Pilot Study Investigating the Clinical Use of Tissue Engineered Vascular Grafts in Congenital Heart Surgery
A Pilot Study Investigating the Clinical Use of Tissue Engineered Vascular Grafts in Congenital Heart Surgery
Status: Enrolling
Updated: 2/28/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Stent Thrombosis In Acute Coronary Syndromes
Contemporary Treatment Of Stent Thrombosis In Acute Coronary Syndromes
Status: Enrolling
Updated:  3/1/2018
UC Davis Medical Center
mi
from
Sacramento, CA
Stent Thrombosis In Acute Coronary Syndromes
Contemporary Treatment Of Stent Thrombosis In Acute Coronary Syndromes
Status: Enrolling
Updated: 3/1/2018
UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Mindful Hearts Study
Mindfulness Based Stress Reduction for Women at Risk for Cardiovascular Disease
Status: Enrolling
Updated:  3/2/2018
Edward Hines Jr. VA Hospital, Hines, IL
mi
from
Hines, IL
Mindful Hearts Study
Mindfulness Based Stress Reduction for Women at Risk for Cardiovascular Disease
Status: Enrolling
Updated: 3/2/2018
Edward Hines Jr. VA Hospital, Hines, IL
mi
from
Hines, IL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Huntsville, AL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Montgomery, AL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Montgomery, AL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Tucson, AZ
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Anaheim, CA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Fresno, CA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Fresno, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Loma Linda, CA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative site
mi
from
Los Angeles, CA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative site
mi
from
Los Angeles, CA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Northridge, CA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Northridge, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Palo Alto, CA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Sacramento, CA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Sacramento, CA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
San Diego, CA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
San Diego, CA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
San Diego, CA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Sylmar, CA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Sylmar, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Walnut Creek, CA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Walnut Creek, CA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Colorado Springs, CO
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis
mi
from
Denver, CO
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis
mi
from
Denver, CO
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Hartford, CT
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Hartford, CT
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Hartford, CT
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Hartford, CT
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Atlantis, FL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Jacksonville, FL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Jacksonville, FL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Jacksonville, FL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Sanford, FL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Sanford, FL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Sarasota, FL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Sarasota, FL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigational Site
mi
from
Tampa, FL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigational Site
mi
from
Tampa, FL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Winter Haven, FL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Winter Haven, FL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Atlanta, GA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Atlanta, GA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Atlanta, GA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Marietta, GA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Marietta, GA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigator Site
mi
from
Chicago, IL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigator Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigator Site
mi
from
Chicago, IL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigator Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigator Site
mi
from
Chicago, IL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigator Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Elk Grove Village, IL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Oakbrook Terrace, IL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Oakbrook Terrace, IL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Peoria, IL
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Peoria, IL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Indianapolis, IN
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Indianapolis, IN
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Muncie, IN
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Muncie, IN
Click here to add this to my saved trials